Abstract
Despite intense research, graft rejection persists as one of the major complications for end-stage chronic renal patients under replacement therapy. Although advancements in surgical techniques and the development of new immunosuppressive drugs have promoted a relative decrease in the incidence and severity of acute rejection, long-term graft survival is still limited due to chronic rejec…